X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-09-27 | MRNA | Afeyan Noubar | Dir | S - Sale | $98.96 | -10,000 | 11,862,969 | 0% | -$989,646 | ||||||
2023-09-20 | MRNA | Afeyan Noubar | Dir | S - Sale | $104.74 | -15,000 | 11,872,969 | 0% | -$1,571,090 | ||||||
2023-09-15 | MRNA | Hoge Stephen | Pres | S - Sale | $112.99 | -15,000 | 1,730,236 | -1% | -$1,694,850 | ||||||
2023-09-13 | MRNA | Afeyan Noubar | Dir | S - Sale | $109.70 | -15,000 | 11,887,969 | 0% | -$1,645,522 | ||||||
| D | 2023-09-08 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $107.22 | -557 | 7,215 | -7% | -$59,722 | |||||
2023-09-06 | MRNA | Afeyan Noubar | Dir | S - Sale | $107.61 | -15,000 | 14,868,952 | 0% | -$1,614,094 | ||||||
| D | 2023-09-06 | MRNA | Garay Arpa | Chief Commercial Officer | S - Sale+OE | $108.40 | -574 | 3,113 | -16% | -$62,219 | |||||
| D | 2023-09-05 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $111.44 | -115 | 6,634 | -2% | -$12,815 | |||||
| D | 2023-09-05 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $111.44 | -320 | 1,745,236 | 0% | -$35,660 | |||||
2023-08-30 | MRNA | Afeyan Noubar | Dir | S - Sale | $115.46 | -15,000 | 14,883,952 | 0% | -$1,731,951 | ||||||
| D | 2023-08-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $115.02 | -1,135 | 1,744,904 | 0% | -$130,542 | |||||
2023-08-23 | MRNA | Afeyan Noubar | Dir | S - Sale | $115.51 | -15,000 | 14,898,952 | 0% | -$1,732,613 | ||||||
2023-08-16 | MRNA | Afeyan Noubar | Dir | S - Sale | $97.56 | -10,000 | 14,913,952 | 0% | -$975,614 | ||||||
2023-08-17 | MRNA | Hoge Stephen | Pres | S - Sale | $100.00 | -15,000 | 1,743,628 | -1% | -$1,500,000 | ||||||
| D | 2023-08-10 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $102.53 | -247 | 1,758,628 | 0% | -$25,325 | |||||
2023-08-02 | MRNA | Afeyan Noubar | Dir | S - Sale | $110.99 | -15,000 | 14,923,952 | 0% | -$1,664,876 | ||||||
2023-07-26 | MRNA | Afeyan Noubar | Dir | S - Sale | $120.42 | -15,000 | 14,938,952 | 0% | -$1,806,229 | ||||||
2023-07-19 | MRNA | Afeyan Noubar | Dir | S - Sale | $125.48 | -15,000 | 14,953,952 | 0% | -$1,882,152 | ||||||
2023-07-17 | MRNA | Hoge Stephen | Pres | S - Sale | $120.60 | -15,000 | 1,758,352 | -1% | -$1,809,000 | ||||||
2023-07-12 | MRNA | Afeyan Noubar | Dir | S - Sale | $125.81 | -15,000 | 14,968,952 | 0% | -$1,887,081 | ||||||
2023-07-05 | MRNA | Afeyan Noubar | Dir | S - Sale | $124.73 | -15,000 | 14,983,952 | 0% | -$1,870,933 | ||||||
2023-06-28 | MRNA | Afeyan Noubar | Dir | S - Sale | $121.54 | -15,000 | 14,998,952 | 0% | -$1,823,160 | ||||||
| D | 2023-06-28 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $121.63 | -27,155 | 21,027,198 | 0% | -$3,302,907 | |||||
2023-06-21 | MRNA | Afeyan Noubar | Dir | S - Sale | $121.95 | -15,000 | 15,013,952 | 0% | -$1,829,227 | ||||||
| DM | 2023-06-21 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $120.70 | -80,000 | 21,027,198 | 0% | -$9,655,714 | |||||
2023-06-14 | MRNA | Afeyan Noubar | Dir | S - Sale | $126.18 | -15,000 | 15,028,952 | 0% | -$1,892,627 | ||||||
| DM | 2023-06-14 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $127.27 | -80,000 | 21,027,198 | 0% | -$10,181,874 | |||||
2023-06-15 | MRNA | Hoge Stephen | Pres | S - Sale | $125.93 | -15,000 | 1,773,352 | -1% | -$1,888,950 | ||||||
2023-06-07 | MRNA | Afeyan Noubar | Dir | S - Sale | $125.91 | -15,000 | 15,043,952 | 0% | -$1,888,601 | ||||||
| DM | 2023-06-07 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $124.91 | -80,000 | 21,027,198 | 0% | -$9,992,784 | |||||
| D | 2023-06-08 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $124.09 | -565 | 6,516 | -8% | -$70,111 | |||||
| D | 2023-06-06 | MRNA | Garay Arpa | Chief Commercial Officer | S - Sale+OE | $125.75 | -2,290 | 2,547 | -47% | -$287,972 | |||||
| D | 2023-06-02 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $130.32 | -110 | 5,942 | -2% | -$14,336 | |||||
| D | 2023-06-02 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $130.32 | -309 | 1,788,352 | 0% | -$40,270 | |||||
2023-05-31 | MRNA | Afeyan Noubar | Dir | S - Sale | $127.36 | -15,000 | 15,058,952 | 0% | -$1,910,322 | ||||||
| DM | 2023-05-31 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $127.44 | -80,000 | 21,027,198 | 0% | -$10,195,031 | |||||
| D | 2023-05-30 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $124.95 | -1,181 | 1,788,010 | 0% | -$147,569 | |||||
| DM | 2023-05-24 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $129.40 | -80,000 | 21,027,198 | 0% | -$10,351,633 | |||||
| DM | 2023-05-17 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $124.55 | -80,000 | 21,027,198 | 0% | -$9,963,647 | |||||
| DM | 2023-05-10 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $129.43 | -80,000 | 21,027,198 | 0% | -$10,354,519 | |||||
| D | 2023-05-10 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $133.37 | -250 | 1,786,781 | 0% | -$33,344 | |||||
| DM | 2023-05-03 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $133.50 | -80,000 | 21,027,198 | 0% | -$10,679,623 | |||||
| DM | 2023-04-26 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $131.17 | -80,000 | 21,027,198 | 0% | -$10,493,710 | |||||
| DM | 2023-04-19 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $142.94 | -80,000 | 21,027,198 | 0% | -$11,434,802 | |||||
| DM | 2023-04-12 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $158.72 | -80,000 | 21,027,198 | 0% | -$12,697,675 | |||||
| DM | 2023-04-05 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $156.06 | -80,000 | 21,027,198 | 0% | -$12,484,535 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |